NFKBIA and Insulin resistance: Interestingly, Kumar and collaborators previously showed that short treatment of rapamycin prevented mTORC1-induced insulin resistance in human podocytes, an effect that was associated with decreased expression of IκBα and phosphorylation NF-κB23.